Refine Search
(107)
(201)
(679)
(1595)

NEW Wearable Technology in Healthcare - Thematic Research

  • $1,950
  • August 2019
Add to Basket Quick View Add to Saved List

Wearables have the potential to transform healthcare through the ability to remotely measure and analyse patient data in real-time. In addition to health and wellness, they have their greatest potential in healthcare to address spiralling healt...

NEW Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

  • $10,995
  • August 2019
Add to Basket Quick View Add to Saved List

Allergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous inhaled substance in the environment with one or more of the following symptoms: rhinorrhea, sneezing, nasal congestio...

NEW CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Saudi Arabia

  • $1,995
  • August 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Saudi Arabia”. The report is an essential source of information and analysis on the healthcare, re...

Hemophilia: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B) (Bolton-Maggs and...

Hidradenitis Suppurativa (HS): Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Hidradenitis Suppurativa (HS) is a long term, recurrent skin condition that causes painful lumps under the skin that form near the hair follicles where there are sweat glands (NHS, 2016; Mayo Clinic, 2018). HS is characterized by abscesses and ...

Female Infertility: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Infertility generally refers to a difficulty in becoming pregnant after trying to conceive for one year, whereas impaired fecundity includes problems either in becoming pregnant or carrying a pregnancy to term (Chandra, Copen and Stephen, 2013)...

Hidradenitis Suppurativa: Opportunity Analysis and Forecasts to 2028

  • $10,995
  • July 2019
Add to Basket Quick View Add to Saved List

Hidradenitis Suppurativa (HS) is a chronic, inflammatory, debilitating skin disease that is characterized by the recurrent development of painful nodules and abscesses that rupture. This leads to the formation of sinus tracts and scarring on th...

Alopecia Areata: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Alopecia areata (AA) is a common, clinically heterogeneous, immune-mediated and a non-scarring hair loss disorder (Hordinsky, 2013). It typically presents with sharply demarcated round patches of hair loss and may present at any age. Experiment...

Allergic Rhinitis: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Allergic rhinitis (AR) is a chronic inflammatory condition of the nasal mucosa, caused by immunoglobulin E (IgE)-mediated early-phase and late-phase hypersensitivity responses (Scadding, 2015). AR symptoms include rhinorrhea, nasal obstruction ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape -Mexico

  • $1,995
  • July 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Mexico”. The report is an essential source of information and analysis on the healthcare, regulato...

Ovarian Cancer: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Ovarian cancer is the most lethal gynecologic cancer and overall a leading cause of cancer incidence and mortality worldwide. The disease is defined as uncontrolled cell growth in the ovaries, although research has shown that the disease may ac...

Brexit and the Healthcare Industry – Implications for Pharma – Q2 2019

  • $500
  • July 2019
Add to Basket Quick View Add to Saved List

It has been over three years since the UK voted to leave the EU. After the UK and the EU agreed to a second delay to Brexit, it is due to happen on 31 October, 2019 and negotiations are still ongoing to determine the UK’s relationship with the ...

Respiratory Syncytial Virus: Epidemiology Forecast to 2028

  • $3,995
  • July 2019
Add to Basket Quick View Add to Saved List

Respiratory syncytial virus (RSV) is a common respiratory infection that most children will be infected with by the time they are two years old. In healthy individuals RSV usually self-resolves within a week or two without need for significant ...

Respiratory Syncytial Virus: Opportunity Analysis and Forecasts to 2028

  • $10,995
  • July 2019
Add to Basket Quick View Add to Saved List

Human respiratory syncytial virus (RSV) is an enveloped, single-stranded, negative-sense RNA orthopneumovirus belonging to the family of Paramyxoviridae. The virus was discovered in 1956, first as an isolate from a laboratory chimpanzee display...

Digital Therapeutics and Their Impact on Healthcare

  • $7,995
  • June 2019
Add to Basket Quick View Add to Saved List

Due to increasing levels in healthcare spending combined with declining R&D returns, digital therapeutics (DTx) represent a new way of treatment in which digital systems are used as regulatory‐approved, to treat medical conditions as prescr...

Allergic Diseases: Pipeline Offers Novel Approaches to Treat Increasingly Prevalent Conditions, with Strong Presence of Cytokine Mediators Among First-in-Class Products

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

An allergy or allergic disease is a condition that arises from an adverse reaction to an exogenous antigen, a substance that invokes an immunological response. These conditions are extremely common. The number of people diagnosed with allergic ...

B-Cell Non-Hodgkin’s Lymphoma (NHL): Opportunity Analysis and Forecasts to 2027

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of proliferative malignancies that arise in the B cells, T cells, or natural killer (NK) cells within the lymphoid tissue, such as the lymph nodes, bone marrow, thymus, and spleen. B-...

B-Cell Non-Hodgkin’s Lymphoma: Epidemiology Forecast to 2027

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Non-Hodgkin’s lymphoma (NHL) refers to a group of cancers that develop in the lymphatic system. In NHL, the patient’s immune system is affected by the uncontrollable growth of malignant white blood cells, resulting in the body’s inability to fi...

Post-Traumatic Stress Disorder (PTSD): Opportunity Analysis and Forecasts to 2028

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

Post-traumatic stress disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent per...

Post-Traumatic Stress Disorder: Epidemiology Forecast to 2028

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Post-Traumatic Stress Disorder (PTSD) is a psychiatric disorder that can occur in people who have experienced or witnessed a traumatic event such as a natural disaster, a serious accident, a terrorist act, war/combat, rape, or other violent per...

Systemic Lupus Erythematosus: Programs Targeting Cytokine and Growth Factor Signaling Dominate First-in-Class Pipeline

  • $6,995
  • June 2019
Add to Basket Quick View Add to Saved List

Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. While SLE can affect multiple major organ systems in the body, one of its most severe...

Spinal Muscular Atrophy (SMA): Opportunity Analysis and Forecasts to 2028

  • $10,995
  • June 2019
Add to Basket Quick View Add to Saved List

SMA is an area that is expected to witness strong growth in the future, primarily due to launch of pipeline products that are expected to gradually capture market share from Biogen’s Spinraza. Also, the launch of survival motor neuron (SMN)- in...

Spinal Muscular Atrophy: Epidemiology Forecast to 2028

  • $3,995
  • June 2019
Add to Basket Quick View Add to Saved List

Spinal muscular atrophy (SMA) is an autosomal recessive neuromuscular disease characterized by degeneration of alpha motor neurons in the spinal cord, resulting in progressive proximal muscle weakness and paralysis. The most common form of SMA ...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Italy

  • $1,995
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Italy”. The report is an essential source of information and analysis on the healthcare, regulator...

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Brazil

  • $1,995
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData, the industry analysis specialist, has released its latest report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape – Brazil”. The report is an essential source of information and analysis on the healthcare, regulato...

Partnerships, Licensing, Investments and M&A Deals and Trends for April 2019 in Pharmaceuticals

  • $1,000
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for April 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and ...

Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals

  • $3,500
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for 2018 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financ...

Partnerships, Licensing, Investments and M&A Deals and Trends for March 2019 in Pharmaceuticals

  • $1,000
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for March 2019 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and ...

Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2019

  • $1,500
  • June 2019
Add to Basket Quick View Add to Saved List

GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals – Q1 2019” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and finan...

Obesity: Gut Hormone Receptors Retain Commercial Prominence

  • $6,995
  • May 2019
Add to Basket Quick View Add to Saved List

Obesity is a chronic and potentially fatal disease. The most prevalent metabolic disorder affecting people today, obesity requires multidisciplinary continuing treatment. Despite the market’s clinical and regulatory challenges, the obesity pipe...

Join our mailing list
Find out first about the latest reports and offers.
Report Catalogue

Strategic Insight Reports

Market Analysis Reports

Databooks